Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects | Signal Transduction and Targeted Therapy
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy | Nature Medicine
CRISPR: gene editing is just the beginning : Nature News & Comment
CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology | npj Precision Oncology
Development of a CRISPR/Cas9-based therapy for Hutchinson–Gilford progeria syndrome | Request PDF
Precision CRISPR system averts hearing loss in mice - Boston Children's Discoveries
The kill-switch for CRISPR that could make gene-editing safer
CRISPR gene editing - Wikipedia
CRISPR-Edited Cells Linked to Cancer Risk in 2 Studies - Scientific American
Four U.S. CRISPR Trials Editing Human DNA to Research New Treatments | Science | Smithsonian Magazine
:no_upscale()/cdn.vox-cdn.com/uploads/chorus_image/image/60457727/CRISPR_LEAD.0.jpg "CRISPR, one of the biggest science stories of the decade, explained - Vox")
CRISPR, one of the biggest science stories of the decade, explained - Vox
Nature Medicine on Twitter: "#CRISPR–Cas9-induced DNA damage triggers p53 to limit the efficiency of #geneediting in immortalized human retinal pigment epithelial cells: https://t.co/Ofc8akirQF… https://t.co/jA1qViiOE7"
PDF) The CRISPR tool kit for genome editing and beyond
New CRISPR genome-editing system can target disease-causing genetic variations – Harvard Gazette
Super-precise new CRISPR tool could tackle a plethora of genetic diseases
Is Crispr the Next Antibiotic? - The New York Times
CRISPR, the disruptor : Nature News & Comment
Nature Medicine - About the cover: Using CRISPR-Cas9–based genome editing technology, Sato and colleagues (featured on p 256 of this month's issue) introduce various combinations of mutations associated with human intestinal tumors
CRISPR-engineered T cells in patients with refractory cancer | Science
CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response | Nature Medicine
Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome. - Nat. Med. - X-MOL
CRISPR algorithm predicts how well gene editing will work - Scope
A CRISPR Approach to Treating Sickle Cell – NIH Director's Blog
Nature Medicine on Twitter: "Two studies find that #AAV-mediated #CRISPR/ Cas9 therapy extends life span and ameliorates disease-related phenotypes in a mouse model of #progeria. https://t.co/2LfOogSXLX and https://t.co/y5KjuD5Yjb… https://t.co/RMaa25wQoI"
Focus on CRISPR tools and therapies | Nature Biotechnology
Nature journal retracts controversial CRISPR paper after authors admit results may be wrong – Retraction Watch
